25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Metagenomi, Inc. Common Stock
Buy, Hold or Sell?

Let's analyze Metagenomi together

I guess you are interested in Metagenomi, Inc. Common Stock. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Metagenomi, Inc. Common Stock. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Metagenomi, Inc. Common Stock

I send you an email if I find something interesting about Metagenomi, Inc. Common Stock.

1. Quick Overview

1.1. Quick analysis of Metagenomi (30 sec.)










1.2. What can you expect buying and holding a share of Metagenomi? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$6.83
Expected worth in 1 year
$16.85
How sure are you?
11.1%

+ What do you gain per year?

Total Gains per Share
$10.01
Return On Investment
410.3%

For what price can you sell your share?

Current Price per Share
$2.44
Expected price per share
$1.83 - $4.92
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Metagenomi (5 min.)




Live pricePrice per Share (EOD)
$2.44

2.2. Growth of Metagenomi (5 min.)




Is Metagenomi growing?

Current yearPrevious yearGrowGrow %
How rich?$255.7m-$92.6m$258.9m155.7%

How much money is Metagenomi making?

Current yearPrevious yearGrowGrow %
Making money-$18.4m-$15.8m-$2.5m-14.0%
Net Profit Margin-149.4%-180.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Metagenomi (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Metagenomi?

Welcome investor! Metagenomi's management wants to use your money to grow the business. In return you get a share of Metagenomi.

First you should know what it really means to hold a share of Metagenomi. And how you can make/lose money.

Speculation

The Price per Share of Metagenomi is $2.44. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Metagenomi.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Metagenomi, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $6.83. Based on the TTM, the Book Value Change Per Share is $2.50 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.79 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Metagenomi.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.50-20.6%-0.49-20.2%-0.42-17.4%-0.44-18.0%-0.44-18.0%
Usd Book Value Change Per Share-0.36-14.9%2.50102.6%-0.79-32.5%0.7631.1%0.7631.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.36-14.9%2.50102.6%-0.79-32.5%0.7631.1%0.7631.1%
Usd Price Per Share2.17-4.20-0.00-1.87-1.87-
Price to Earnings Ratio-1.08--2.14-0.00--0.95--0.95-
Price-to-Total Gains Ratio-5.95--9.85--9.85--9.85-
Price to Book Ratio0.32-0.58-0.00-0.26-0.26-
Price-to-Total Gains Ratio-5.95--9.85--9.85--9.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.44
Number of shares409
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share2.500.76
Usd Total Gains Per Share2.500.76
Gains per Quarter (409 shares)1,023.60310.59
Gains per Year (409 shares)4,094.381,242.36
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1040944084012421232
2081898178024852474
301228312272037273716
401637816366049694958
502047220460062126200
602456624554074547442
702866128648086968684
803275532742099399926
90368493683601118111168
100409444093001242412410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.09.00.00.0%0.09.00.00.0%0.09.00.00.0%0.09.00.00.0%
Book Value Change Per Share1.03.00.025.0%1.07.01.011.1%1.07.01.011.1%1.07.01.011.1%1.07.01.011.1%
Dividend per Share0.00.04.00.0%0.00.09.00.0%0.00.09.00.0%0.00.09.00.0%0.00.09.00.0%
Total Gains per Share1.03.00.025.0%1.07.01.011.1%1.07.01.011.1%1.07.01.011.1%1.07.01.011.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Metagenomi, Inc. Common Stock compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.3652.503-115%-0.794+118%0.759-148%0.759-148%
Book Value Per Share--6.8344.445+54%-2.473+136%0.877+680%0.877+680%
Current Ratio--6.1785.198+19%4.240+46%4.195+47%4.195+47%
Debt To Asset Ratio--0.2860.574-50%1.230-77%0.802-64%0.802-64%
Debt To Equity Ratio--0.4010.335+20%0.450-11%0.349+15%0.349+15%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--253221863.000390601173.333-35%--390601173.333-35%390601173.333-35%
Eps---0.502-0.494-2%-0.424-15%-0.439-12%-0.439-12%
Ev To Ebitda Ratio---3.012-4.553+51%---4.553+51%-4.553+51%
Ev To Sales Ratio--5.4987.582-27%--7.582-27%7.582-27%
Free Cash Flow Per Share---0.744-0.721-3%-0.098-87%-0.418-44%-0.418-44%
Free Cash Flow To Equity Per Share---0.757-0.168-78%0.553-237%0.117-747%0.117-747%
Gross Profit Margin--1.0001.030-3%1.012-1%1.024-2%1.024-2%
Market Cap91314316.000+11%81209863.000157180380.000-48%-+100%69857946.667+16%69857946.667+16%
Net Profit Margin---1.630-1.494-8%-1.807+11%-1.702+4%-1.702+4%
Operating Margin---1.944-1.681-14%-1.756-10%-1.773-9%-1.773-9%
Operating Ratio--2.9442.470+19%3.698-20%3.098-5%3.098-5%
Pb Ratio0.357+11%0.3180.579-45%-+100%0.257+23%0.257+23%
Pe Ratio-1.216-12%-1.081-2.140+98%--100%-0.951-12%-0.951-12%
Price Per Share2.440+11%2.1704.200-48%-+100%1.867+16%1.867+16%
Price To Free Cash Flow Ratio-0.820-12%-0.729-1.338+83%--100%-0.595-18%-0.595-18%
Price To Total Gains Ratio-6.692-12%-5.951-9.854+66%---9.854+66%-9.854+66%
Quick Ratio--11.4828.856+30%6.848+68%6.980+65%6.980+65%
Return On Assets---0.052-0.048-8%-0.039-25%-0.039-26%-0.039-26%
Return On Equity---0.073-0.051-30%-0.015-80%-0.029-60%-0.029-60%
Total Gains Per Share---0.3652.503-115%-0.794+118%0.759-148%0.759-148%
Usd Book Value--255773000.000166310250.000+54%-92604000.000+136%32758333.333+681%32758333.333+681%
Usd Book Value Change Per Share---0.3652.503-115%-0.794+118%0.759-148%0.759-148%
Usd Book Value Per Share--6.8344.445+54%-2.473+136%0.877+680%0.877+680%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--253221863.000390601173.333-35%--390601173.333-35%390601173.333-35%
Usd Eps---0.502-0.494-2%-0.424-15%-0.439-12%-0.439-12%
Usd Free Cash Flow---27838000.000-26976500.000-3%-3667250.000-87%-15644111.111-44%-15644111.111-44%
Usd Free Cash Flow Per Share---0.744-0.721-3%-0.098-87%-0.418-44%-0.418-44%
Usd Free Cash Flow To Equity Per Share---0.757-0.168-78%0.553-237%0.117-747%0.117-747%
Usd Market Cap91314316.000+11%81209863.000157180380.000-48%-+100%69857946.667+16%69857946.667+16%
Usd Price Per Share2.440+11%2.1704.200-48%-+100%1.867+16%1.867+16%
Usd Profit---18773000.000-18488500.000-2%-15897000.000-15%-16435888.889-12%-16435888.889-12%
Usd Revenue--11514000.00013770000.000-16%9488000.000+21%10882777.778+6%10882777.778+6%
Usd Total Gains Per Share---0.3652.503-115%-0.794+118%0.759-148%0.759-148%
 EOD+5 -3MRQTTM+10 -28YOY+19 -145Y+16 -2210Y+16 -22

3.3 Fundamental Score

Let's check the fundamental score of Metagenomi, Inc. Common Stock based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.216
Price to Book Ratio (EOD)Between0-10.357
Net Profit Margin (MRQ)Greater than0-1.630
Operating Margin (MRQ)Greater than0-1.944
Quick Ratio (MRQ)Greater than111.482
Current Ratio (MRQ)Greater than16.178
Debt to Asset Ratio (MRQ)Less than10.286
Debt to Equity Ratio (MRQ)Less than10.401
Return on Equity (MRQ)Greater than0.15-0.073
Return on Assets (MRQ)Greater than0.05-0.052
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Metagenomi, Inc. Common Stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.967
Ma 20Greater thanMa 502.608
Ma 50Greater thanMa 1003.074
Ma 100Greater thanMa 2002.531
OpenGreater thanClose2.530
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Metagenomi, Inc. Common Stock

Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company's genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, such as prime editing systems and clustered regularly interspaced short palindromic repeat-associated transposases. It has a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited T-cell receptor-based therapeutic products in the field of treatment, prevention, or diagnosis of human cancer; and a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop, and commercialize investigational medicines using genome editing technologies. The company was incorporated in 2016 and is based in Emeryville, California.

Fundamental data was last updated by Penke on 2025-02-17 00:18:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Metagenomi earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Metagenomi to the Biotechnology industry mean.
  • A Net Profit Margin of -163.0% means that $-1.63 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Metagenomi, Inc. Common Stock:

  • The MRQ is -163.0%. The company is making a huge loss. -2
  • The TTM is -149.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-163.0%TTM-149.4%-13.6%
TTM-149.4%YOY-180.7%+31.3%
TTM-149.4%5Y-170.2%+20.8%
5Y-170.2%10Y-170.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-163.0%-99.4%-63.6%
TTM-149.4%-211.5%+62.1%
YOY-180.7%-210.1%+29.4%
5Y-170.2%-346.2%+176.0%
10Y-170.2%-489.2%+319.0%
4.3.1.2. Return on Assets

Shows how efficient Metagenomi is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Metagenomi to the Biotechnology industry mean.
  • -5.2% Return on Assets means that Metagenomi generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Metagenomi, Inc. Common Stock:

  • The MRQ is -5.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.2%TTM-4.8%-0.4%
TTM-4.8%YOY-3.9%-0.9%
TTM-4.8%5Y-3.9%-0.9%
5Y-3.9%10Y-3.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.2%-12.0%+6.8%
TTM-4.8%-12.1%+7.3%
YOY-3.9%-11.4%+7.5%
5Y-3.9%-12.8%+8.9%
10Y-3.9%-14.5%+10.6%
4.3.1.3. Return on Equity

Shows how efficient Metagenomi is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Metagenomi to the Biotechnology industry mean.
  • -7.3% Return on Equity means Metagenomi generated $-0.07 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Metagenomi, Inc. Common Stock:

  • The MRQ is -7.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.3%TTM-5.1%-2.2%
TTM-5.1%YOY-1.5%-3.6%
TTM-5.1%5Y-2.9%-2.2%
5Y-2.9%10Y-2.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.3%-15.4%+8.1%
TTM-5.1%-16.1%+11.0%
YOY-1.5%-14.7%+13.2%
5Y-2.9%-18.5%+15.6%
10Y-2.9%-19.5%+16.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Metagenomi, Inc. Common Stock.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Metagenomi is operating .

  • Measures how much profit Metagenomi makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Metagenomi to the Biotechnology industry mean.
  • An Operating Margin of -194.4% means the company generated $-1.94  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Metagenomi, Inc. Common Stock:

  • The MRQ is -194.4%. The company is operating very inefficient. -2
  • The TTM is -168.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-194.4%TTM-168.1%-26.3%
TTM-168.1%YOY-175.6%+7.4%
TTM-168.1%5Y-177.3%+9.2%
5Y-177.3%10Y-177.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-194.4%-202.6%+8.2%
TTM-168.1%-313.2%+145.1%
YOY-175.6%-214.2%+38.6%
5Y-177.3%-371.8%+194.5%
10Y-177.3%-492.1%+314.8%
4.3.2.2. Operating Ratio

Measures how efficient Metagenomi is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.94 means that the operating costs are $2.94 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Metagenomi, Inc. Common Stock:

  • The MRQ is 2.944. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.470. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.944TTM2.470+0.474
TTM2.470YOY3.698-1.229
TTM2.4705Y3.098-0.629
5Y3.09810Y3.0980.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9442.129+0.815
TTM2.4703.198-0.728
YOY3.6983.358+0.340
5Y3.0984.842-1.744
10Y3.0986.500-3.402
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Metagenomi, Inc. Common Stock.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Metagenomi is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.18 means the company has $6.18 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Metagenomi, Inc. Common Stock:

  • The MRQ is 6.178. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.198. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.178TTM5.198+0.980
TTM5.198YOY4.240+0.957
TTM5.1985Y4.195+1.003
5Y4.19510Y4.1950.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.1783.608+2.570
TTM5.1983.871+1.327
YOY4.2404.591-0.351
5Y4.1955.971-1.776
10Y4.1956.216-2.021
4.4.3.2. Quick Ratio

Measures if Metagenomi is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Metagenomi to the Biotechnology industry mean.
  • A Quick Ratio of 11.48 means the company can pay off $11.48 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Metagenomi, Inc. Common Stock:

  • The MRQ is 11.482. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.856. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ11.482TTM8.856+2.626
TTM8.856YOY6.848+2.008
TTM8.8565Y6.980+1.876
5Y6.98010Y6.9800.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.4823.075+8.407
TTM8.8563.351+5.505
YOY6.8484.393+2.455
5Y6.9805.972+1.008
10Y6.9806.463+0.517
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Metagenomi, Inc. Common Stock.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Metagenomi assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Metagenomi to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.29 means that Metagenomi assets are financed with 28.6% credit (debt) and the remaining percentage (100% - 28.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Metagenomi, Inc. Common Stock:

  • The MRQ is 0.286. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.574. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.286TTM0.574-0.288
TTM0.574YOY1.230-0.655
TTM0.5745Y0.802-0.228
5Y0.80210Y0.8020.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2860.342-0.056
TTM0.5740.345+0.229
YOY1.2300.315+0.915
5Y0.8020.363+0.439
10Y0.8020.384+0.418
4.5.4.2. Debt to Equity Ratio

Measures if Metagenomi is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Metagenomi to the Biotechnology industry mean.
  • A Debt to Equity ratio of 40.1% means that company has $0.40 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Metagenomi, Inc. Common Stock:

  • The MRQ is 0.401. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.335. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.401TTM0.335+0.066
TTM0.335YOY0.450-0.115
TTM0.3355Y0.349-0.014
5Y0.34910Y0.3490.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4010.387+0.014
TTM0.3350.428-0.093
YOY0.4500.391+0.059
5Y0.3490.450-0.101
10Y0.3490.495-0.146
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Metagenomi generates.

  • Above 15 is considered overpriced but always compare Metagenomi to the Biotechnology industry mean.
  • A PE ratio of -1.08 means the investor is paying $-1.08 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Metagenomi, Inc. Common Stock:

  • The EOD is -1.216. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.081. Based on the earnings, the company is expensive. -2
  • The TTM is -2.140. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.216MRQ-1.081-0.135
MRQ-1.081TTM-2.140+1.059
TTM-2.140YOY--2.140
TTM-2.1405Y-0.951-1.189
5Y-0.95110Y-0.9510.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.216-2.261+1.045
MRQ-1.081-2.752+1.671
TTM-2.140-3.224+1.084
YOY--3.405+3.405
5Y-0.951-6.128+5.177
10Y-0.951-6.735+5.784
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Metagenomi, Inc. Common Stock:

  • The EOD is -0.820. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.729. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.338. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.820MRQ-0.729-0.091
MRQ-0.729TTM-1.338+0.609
TTM-1.338YOY--1.338
TTM-1.3385Y-0.595-0.743
5Y-0.59510Y-0.5950.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.820-3.073+2.253
MRQ-0.729-3.602+2.873
TTM-1.338-3.827+2.489
YOY--4.448+4.448
5Y-0.595-8.209+7.614
10Y-0.595-9.216+8.621
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Metagenomi is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.32 means the investor is paying $0.32 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Metagenomi, Inc. Common Stock:

  • The EOD is 0.357. Based on the equity, the company is cheap. +2
  • The MRQ is 0.318. Based on the equity, the company is cheap. +2
  • The TTM is 0.579. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.357MRQ0.318+0.040
MRQ0.318TTM0.579-0.262
TTM0.579YOY-+0.579
TTM0.5795Y0.257+0.322
5Y0.25710Y0.2570.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.3571.942-1.585
MRQ0.3182.252-1.934
TTM0.5792.427-1.848
YOY-2.470-2.470
5Y0.2573.770-3.513
10Y0.2574.507-4.250
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Metagenomi, Inc. Common Stock.

4.8.3. Insider Transactions

Insiders are holding 28.809% of the shares of Metagenomi, Inc. Common Stock.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-12-05Pamela WapnickSELL15591.86
2024-09-05Pamela WapnickSELL62652.88
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Net Debt  -53,690-38,684-92,37437,878-54,49641,256-13,24034,19620,956
Accumulated Other Comprehensive Income  -359262-97-181-27813-2651,9041,639



5.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets358,348
Total Liabilities102,575
Total Stockholder Equity255,773
 As reported
Total Liabilities 102,575
Total Stockholder Equity+ 255,773
Total Assets = 358,348

Assets

Total Assets358,348
Total Current Assets282,293
Long-term Assets76,055
Total Current Assets
Cash And Cash Equivalents 25,117
Short-term Investments 249,470
Net Receivables 589
Other Current Assets 7,117
Total Current Assets  (as reported)282,293
Total Current Assets  (calculated)282,293
+/-0
Long-term Assets
Property Plant Equipment 59,910
Long Term Investments 10,577
Long-term Assets Other 5,568
Long-term Assets  (as reported)76,055
Long-term Assets  (calculated)76,055
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities45,692
Long-term Liabilities56,883
Total Stockholder Equity255,773
Total Current Liabilities
Short-term Debt 4,696
Accounts payable 3,103
Other Current Liabilities 8,840
Total Current Liabilities  (as reported)45,692
Total Current Liabilities  (calculated)16,639
+/- 29,053
Long-term Liabilities
Capital Lease Obligations 46,073
Long-term Liabilities Other 3,075
Long-term Liabilities  (as reported)56,883
Long-term Liabilities  (calculated)49,148
+/- 7,735
Total Stockholder Equity
Common Stock4
Retained Earnings -199,604
Accumulated Other Comprehensive Income 1,639
Other Stockholders Equity 453,734
Total Stockholder Equity (as reported)255,773
Total Stockholder Equity (calculated)255,773
+/-0
Other
Capital Stock4
Cash and Short Term Investments 274,587
Common Stock Shares Outstanding 36,766
Current Deferred Revenue29,053
Liabilities and Stockholders Equity 358,348
Net Debt 20,956
Net Invested Capital 255,773
Net Working Capital 236,601
Property Plant and Equipment Gross 59,910
Short Long Term Debt Total 46,073



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-30
> Total Assets 
0
414,486
0
408,659
386,433
364,842
415,403
385,905
358,348
358,348385,905415,403364,842386,433408,6590414,4860
   > Total Current Assets 
0
366,899
362,131
324,238
300,003
278,273
335,643
307,579
282,293
282,293307,579335,643278,273300,003324,238362,131366,8990
       Cash And Cash Equivalents 
0
184,441
-362,131
51,648
101,897
140,603
102,558
61,181
25,117
25,11761,181102,558140,603101,89751,648-362,131184,4410
       Short-term Investments 
0
177,690
724,262
266,792
191,030
130,579
224,847
238,740
249,470
249,470238,740224,847130,579191,030266,792724,262177,6900
       Net Receivables 
0
1,274
0
3,485
3,924
2,451
2,082
1,648
589
5891,6482,0822,4513,9243,48501,2740
       Other Current Assets 
0
3,494
0
1,694
3,152
4,640
6,156
6,010
7,117
7,1176,0106,1564,6403,1521,69403,4940
   > Long-term Assets 
0
47,587
-362,131
84,421
86,430
86,569
79,760
78,326
76,055
76,05578,32679,76086,56986,43084,421-362,13147,5870
       Property Plant Equipment 
0
33,258
0
66,374
65,688
65,153
63,457
62,070
59,910
59,91062,07063,45765,15365,68866,374033,2580
       Long Term Investments 
0
7,806
0
10,676
10,676
10,676
10,676
10,676
10,577
10,57710,67610,67610,67610,67610,67607,8060
       Other Assets 
0
0
0
0
0
0
0
0
0
000000000
> Total Liabilities 
0
488,914
0
511,198
505,454
500,426
139,770
116,486
102,575
102,575116,486139,770500,426505,454511,1980488,9140
   > Total Current Liabilities 
0
48,537
0
64,331
68,782
68,861
70,701
52,810
45,692
45,69252,81070,70168,86168,78264,331048,5370
       Short-term Debt 
0
1,515
0
1,843
2,269
3,427
4,382
5,396
4,696
4,6965,3964,3823,4272,2691,84301,5150
       Accounts payable 
0
2,011
0
2,993
4,893
1,791
6,843
3,453
3,103
3,1033,4536,8431,7914,8932,99302,0110
       Other Current Liabilities 
0
11,069
0
13,488
59,452
60,377
56,210
43,961
8,840
8,84043,96156,21060,37759,45213,488011,0690
   > Long-term Liabilities 
0
440,377
0
446,867
436,672
431,565
69,069
63,676
56,883
56,88363,67669,069431,565436,672446,8670440,3770
> Total Stockholder Equity
0
-74,428
271,675
-102,539
-119,021
-135,584
275,633
269,419
255,773
255,773269,419275,633-135,584-119,021-102,539271,675-74,4280
   Common Stock
0
2,535
0
3,720
6,988
9,457
4
4
4
4449,4576,9883,72002,5350
   Retained Earnings Total Equity000000000
   Accumulated Other Comprehensive Income 
0
-274
-74,428
-429
-359
-97
-278
-265
1,639
1,639-265-278-97-359-429-74,428-2740
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
0
-346,103
0
0
6,962
-341,327
445,999
450,511
453,734
453,734450,511445,999-341,3276,96200-346,1030



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-09-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue44,756
Cost of Revenue-94,403
Gross Profit-49,647-49,647
 
Operating Income (+$)
Gross Profit-49,647
Operating Expense-123,248
Operating Income-78,492-172,895
 
Operating Expense (+$)
Research Development94,403
Selling General Administrative28,845
Selling And Marketing Expenses0
Operating Expense123,248123,248
 
Net Interest Income (+$)
Interest Income15,468
Interest Expense-0
Other Finance Cost-0
Net Interest Income15,468
 
Pretax Income (+$)
Operating Income-78,492
Net Interest Income15,468
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-60,228-96,756
EBIT - interestExpense = -60,228
-60,228
-68,255
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-60,228-60,228
Earnings Before Interest and Taxes (EBITDA)-56,021
 
After tax Income (+$)
Income Before Tax-60,228
Tax Provision-8,027
Net Income From Continuing Ops-68,255-68,255
Net Income-68,255
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses123,248
Total Other Income/Expenses Net18,264-15,468
 

Technical Analysis of Metagenomi
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Metagenomi. The general trend of Metagenomi is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Metagenomi's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Metagenomi, Inc. Common Stock.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4 < 4.4 < 4.92.

The bearish price targets are: 2.34 > 2.25 > 1.83.

Tweet this
Metagenomi, Inc. Common Stock Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Metagenomi, Inc. Common Stock. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Metagenomi, Inc. Common Stock Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Metagenomi, Inc. Common Stock. The current macd is -0.13943431.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Metagenomi price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Metagenomi. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Metagenomi price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Metagenomi, Inc. Common Stock Daily Moving Average Convergence/Divergence (MACD) ChartMetagenomi, Inc. Common Stock Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Metagenomi, Inc. Common Stock. The current adx is 13.14.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Metagenomi shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Metagenomi, Inc. Common Stock Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Metagenomi, Inc. Common Stock. The current sar is 2.77719001.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Metagenomi, Inc. Common Stock Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Metagenomi, Inc. Common Stock. The current rsi is 43.97. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Metagenomi, Inc. Common Stock Daily Relative Strength Index (RSI) ChartMetagenomi, Inc. Common Stock Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Metagenomi, Inc. Common Stock. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Metagenomi price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Metagenomi, Inc. Common Stock Daily Stochastic Oscillator ChartMetagenomi, Inc. Common Stock Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Metagenomi, Inc. Common Stock. The current cci is -70.42037328.

Metagenomi, Inc. Common Stock Daily Commodity Channel Index (CCI) ChartMetagenomi, Inc. Common Stock Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Metagenomi, Inc. Common Stock. The current cmo is -12.02358104.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Metagenomi, Inc. Common Stock Daily Chande Momentum Oscillator (CMO) ChartMetagenomi, Inc. Common Stock Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Metagenomi, Inc. Common Stock. The current willr is -72.85714286.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Metagenomi is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Metagenomi, Inc. Common Stock Daily Williams %R ChartMetagenomi, Inc. Common Stock Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Metagenomi, Inc. Common Stock.

Metagenomi, Inc. Common Stock Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Metagenomi, Inc. Common Stock. The current atr is 0.27534382.

Metagenomi, Inc. Common Stock Daily Average True Range (ATR) ChartMetagenomi, Inc. Common Stock Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Metagenomi, Inc. Common Stock. The current obv is 73,899,783.

Metagenomi, Inc. Common Stock Daily On-Balance Volume (OBV) ChartMetagenomi, Inc. Common Stock Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Metagenomi, Inc. Common Stock. The current mfi is 50.62.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Metagenomi, Inc. Common Stock Daily Money Flow Index (MFI) ChartMetagenomi, Inc. Common Stock Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Metagenomi, Inc. Common Stock.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-09-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-10-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-10-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-23MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Metagenomi, Inc. Common Stock Daily Candlestick Chart
DateCandlestick Pattern
2025-02-18Bearish Engulfing Candle Pattern

6.4. Technical Score

Let's check the technical score of Metagenomi, Inc. Common Stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.967
Ma 20Greater thanMa 502.608
Ma 50Greater thanMa 1003.074
Ma 100Greater thanMa 2002.531
OpenGreater thanClose2.530
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Metagenomi with someone you think should read this too:
  • Are you bullish or bearish on Metagenomi? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Metagenomi? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Metagenomi, Inc. Common Stock

I send you an email if I find something interesting about Metagenomi, Inc. Common Stock.


Comments

How you think about this?

Leave a comment

Stay informed about Metagenomi, Inc. Common Stock.

Receive notifications about Metagenomi, Inc. Common Stock in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.